208 related articles for article (PubMed ID: 8537148)
21. The effects of nondepleting CD4 targeted therapy in presensitized rat recipients of cardiac allografts.
Binder J; Lehmann M; Graser E; Hancock WW; Watschinger B; Onodera K; Sayegh MH; Volk HD; Kupiec-Weglinski JW
Transplantation; 1996 Mar; 61(5):804-11. PubMed ID: 8607187
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate regulates ICAM-1 expression in recipients of rat cardiac allografts.
Ciesielski CJ; Pflug JJ; Mei J; Piccinini LA
Transpl Immunol; 1998 Jun; 6(2):111-21. PubMed ID: 9777700
[TBL] [Abstract][Full Text] [Related]
24. Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguanidine.
Ziolo MT; Dollinger SJ; Wahler GM
J Mol Cell Cardiol; 1998 May; 30(5):1009-17. PubMed ID: 9618241
[TBL] [Abstract][Full Text] [Related]
25. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat.
Cattell V; Smith J; Jansen A; Riveros-Moreno V; Moncada S
Transplantation; 1994 Dec; 58(12):1399-402. PubMed ID: 7528951
[TBL] [Abstract][Full Text] [Related]
26. Differential localization of allograft nitric oxide synthesis: comparison of liver and heart transplantation in the rat model.
Kuo PC; Alfrey EJ; Krieger NR; Abe KY; Huie P; Sibley RK; Dafoe DC
Immunology; 1996 Apr; 87(4):647-53. PubMed ID: 8675222
[TBL] [Abstract][Full Text] [Related]
27. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW
Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831
[TBL] [Abstract][Full Text] [Related]
28. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
[TBL] [Abstract][Full Text] [Related]
29. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
Shears LL; Kawaharada N; Tzeng E; Billiar TR; Watkins SC; Kovesdi I; Lizonova A; Pham SM
J Clin Invest; 1997 Oct; 100(8):2035-42. PubMed ID: 9329968
[TBL] [Abstract][Full Text] [Related]
30. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
[TBL] [Abstract][Full Text] [Related]
31. Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection.
Worrall NK; Boasquevisque CH; Misko TP; Sullivan PM; Ferguson TB; Patterson GA
J Heart Lung Transplant; 1997 Mar; 16(3):334-9. PubMed ID: 9087877
[TBL] [Abstract][Full Text] [Related]
32. The effect of selective inhibition of cyclooxygenase (COX)-2 on acute cardiac allograft rejection.
Ma N; Szabolcs MJ; Sun J; Albala A; Sciacca RR; Zhong M; Edwards N; Cannon PJ
Transplantation; 2002 Dec; 74(11):1528-34. PubMed ID: 12490785
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection.
Worrall NK; Boasquevisque CH; Botney MD; Misko TP; Sullivan PM; Ritter JH; Ferguson TB; Patterson GA
Transplantation; 1997 Apr; 63(8):1095-101. PubMed ID: 9133470
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine treatment preserves coronary resistance artery function in rat cardiac allografts.
Moien-Afshari F; Choy JC; McManus BM; Laher I
J Heart Lung Transplant; 2004 Feb; 23(2):193-203. PubMed ID: 14761767
[TBL] [Abstract][Full Text] [Related]
35. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro.
Balligand JL; Ungureanu-Longrois D; Simmons WW; Pimental D; Malinski TA; Kapturczak M; Taha Z; Lowenstein CJ; Davidoff AJ; Kelly RA
J Biol Chem; 1994 Nov; 269(44):27580-8. PubMed ID: 7525557
[TBL] [Abstract][Full Text] [Related]
36. Acute cardiac allograft rejection in nitric oxide synthase-2(-/-) and nitric oxide synthase-2(+/+) mice: effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis.
Szabolcs MJ; Ma N; Athan E; Zhong J; Ming M; Sciacca RR; Husemann J; Albala A; Cannon PJ
Circulation; 2001 May; 103(20):2514-20. PubMed ID: 11369694
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection.
Worrall NK; Misko TP; Sullivan PM; Hui JJ; Ferguson TB
Ann Thorac Surg; 1996 Aug; 62(2):378-85. PubMed ID: 8694595
[TBL] [Abstract][Full Text] [Related]
38. Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro.
Luss H; Watkins SC; Freeswick PD; Imro AK; Nussler AK; Billiar TR; Simmons RL; del Nido PJ; McGowan FX
J Mol Cell Cardiol; 1995 Sep; 27(9):2015-29. PubMed ID: 8523461
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection.
Vos IH; Joles JA; Schurink M; Weckbecker G; Stojanovic T; Rabelink TJ; Gröne HJ
Eur J Pharmacol; 2000 Mar; 391(1-2):31-8. PubMed ID: 10720632
[TBL] [Abstract][Full Text] [Related]
40. Anti-TNF-alpha treatment down-regulates the expression of fibronectin and decreases cellular infiltration of cardiac allografts in rats.
Coito AJ; Binder J; Brown LF; de Sousa M; Van de Water L; Kupiec-Weglinski JW
J Immunol; 1995 Mar; 154(6):2949-58. PubMed ID: 7876561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
